In a previous study, a collection of 55 Legionella pneumophila mutants defective for macrophage killing was isolated by transposon mutagenesis. In this study, nine of these mutants that belong to the same DNA hybridization group (group 3) were characterized. A wild-type DNA fragment that covers this DNA hybridization group was cloned and sequenced. This region was found to contain six new genes (designated icmT, icmS, icmR, icmQ, icmP, and icmO), five of which contain at least one transposon insertion. No transposon insertion was found in icmS. However, this gene was found to be required for macrophage killing, since a kanamycin resistance cassette introduced into icmS by gene replacement resulted in a mutant that was attenuated for macrophage killing. A plasmid containing the DNA fragment that covers this region complements all the mutants for macrophage killing, although various levels of complementation were observed for mutants in different genes. Complementation tests were also performed with plasmids containing one or two of these genes, as well as with plasmids containing nonpolar in-frame deletions. The results from these complementation tests indicated that all six genes located in this region are needed for macrophage killing and that they are probably arranged as two transcriptional units (icmTS and icmPO) and two genes (icmR and icmQ). A region upstream of the coding sequence of several icm genes may contain a potential promoter and/or regulatory site. Homology searches show that icmP and icmO bear significant homology to the trbA and trbC genes from the Salmonella R64 plasmid, respectively. The sequences of the other four genes do not show significant homology with any entries in sequence databases.
Legionella pneumophila, the causative agent of Legionnaires' disease, is a facultatively intracellular pathogen. The bacteria are able to infect, multiply within, and kill human macrophages, as well as free-living amoebae (15, 26) . The pathway for a successful L. pneumophila infection of human macrophages begins with attachment of the bacterium to the host cells via the complement receptors CR1 and CR3 (4, 35) . Attachment is followed by an uptake mechanism known as coiling phagocytosis (24) . The bacterium is then found in a specialized phagosome that does not fuse with lysosomes (23) . This phagosome is sequentially associated with smooth vesicles, mitochondria, and the rough endoplasmic reticulum (22, 40) . Then the bacteria multiply within the phagosome, and the cell eventually lyses, releasing L. pneumophila organisms that can start new rounds of infection.
To date, only a few well-defined virulence factors of L. pneumophila are known. A region reported to contain the icmWXYZ genes was shown to be required for intracellular replication (8) . The dotA gene (transcribed divergently from icmWXYZ) was shown to be required for intracellular replication and organelle recruitment (5, 6) , and recently it was shown to be located in the bacterial inner membrane (13) . The Mip protein was shown to be responsible for efficient initiation of intracellular infection of human macrophages, and a mip mutant was shown to be less infective for human macrophages, as well as for Acanthamoeba castellanii (10, 11) . The Mip protein exhibits peptidyl-prolyl cis/trans isomerase activity, but this activity was shown not to be required for intracellular survival (43) . In addition, strains with mutations in the eml locus were found to have reduced cytopathicity for U937 cells and for Hartmannella veriformis (1) . Although these genes (icmWXYZ, dotA, mip, and eml) were shown to be required for intracellular infection by L. pneumophila, their function remains unknown. The major outer membrane protein, a porin encoded by the ompS gene (18, 19) , is another candidate for being a virulence factor. This protein plays a role during infection, as it binds the complement components C3b and C3bi, which bind to the CR1 and CR3 receptors (4) ; this binding results in the internalization of the bacteria. However, the ompS gene has not been shown to be required for macrophage killing.
In a previous report (36) , a collection of 55 L. pneumophila transposon insertion mutants defective for macrophage killing was identified. The mutants were assigned to 16 DNA hybridization groups, one of which has been already characterized as the icmWXYZ-dotA locus (8) .
The aim of this study was to characterize additional genes that are required for macrophage killing by L. pneumophila. The region described here was found to contain six new genes (icmTSRQPO), all of which were found to be required for macrophage killing. Complementation analysis indicates that these genes are probably organized as two operons (icmTS and icmPO) and two genes (icmR and icmQ). (25) or on ABCYE agar plates (14) . Escherichia coli was grown in Luria-Bertani (LB) broth or on LB agar plates (32) . All reagents and chemicals were purchased from Fisher. For cell culture, RPMI 1640 was obtained from JRH Biosciences, fetal bovine serum (FBS) was obtained from Sigma, and L-glutamine (Gln) was obtained from Cellgro. Normal human serum (NHS) was obtained from healthy volunteers. Enzymes were supplied by New England Biolabs and Boehringer Mannheim Biochemicals. The concentrations of antibiotics for L. pneumophila were as follows: kanamycin (KM), 50 g/ml; chloramphenicol (CM), 5 g/ml.
MATERIALS AND METHODS

Media and reagents. L. pneumophila was grown in AYE broth
Antibiotics for E. coli were as follows: KM, 50 g/ml; CM, 25 g/ml; ampicillin, 100 g/ml.
Bacterial strains, plasmids, and DNA manipulations. Bacterial strains and plasmids used in this work are described in Tables 1 and 2 , respectively. E. coli MC1022 was used for all DNA manipulations. Preparation of plasmid DNA and DNA cloning procedures were performed as described elsewhere (30, 37) . Colony hybridization, Southern hybridization, and chromosomal DNA preparation were performed as described elsewhere (38) . Bacterial mating was carried out as described previously (36) .
Construction of plasmids for complementation. The cloning vectors pMMB207 (33) and pHG-165 (39) were used to construct a new L. pneumophila cloning vector-pMMB207␣b. pMMB207 was digested with XmnI and EcoRI; after the two sites were filled in, the HpaI-HpaI fragment containing the lacZЈ ␣ complementation cassette from pHG-165 was cloned into it to generate pMMB207␣b. This vector was used in this study.
First, a wild-type DNA fragment that covers the region of hybridization group 3 (36) was cloned. The L. pneumophila pLAFR1 library (41) was screened by using a 0.3-kb BssHII fragment (bases 3683 to 4011 in the sequence) generated from the plasmid pAB-16 (36) . Several positive cosmids were identified, and the same 8.8-kb EcoRI fragment was present in all of them (and some other EcoRI fragments as well). The 8.8-kb EcoRI fragment from one of these cosmids (pGS-cos-1) was cloned into the EcoRI site of pMMB207␣b to generate pGSLc-32. All the subclones described below were constructed from pGS-Lc-32 and were cloned into the HincII site of pUC-18 in both orientations (the letter "b" at the end of the plasmid name indicates an orientation opposite to that of the vector promoter). A 1,142-bp fragment containing icmT and icmS was subcloned by using the BsaBI and DraIII sites (bases 1 to 1142 in the sequence) to generate pGS-Lp-37 and pGS-Lp-37b. A 644-bp fragment containing icmR was subcloned by using the ApaI and StuI sites (bases 942 to 1586 in the sequence) to generate pGS-Lp-36 and pGS-Lp-36b. A 1,037-bp fragment containing icmQ was subcloned by using the SacI and NarI sites (bases 1309 to 2346 in the sequence) to generate pGS-Lp-35 and pGS-Lp-35b. A 4,470-bp fragment containing icmP and icmO was subcloned by using the EcoRV and Eco47III sites (bases 1957 to 6432 in the sequence) to generate pGS-Lp-34 and pGS-Lp-34b. The inserts of the eight plasmids described above were cloned into pMMB207␣b by using the EcoRI and HindIII sites of the polylinker. The internal letters of the plasmid name were changed from "Lp" to "Lc" to indicate the different vector; the plasmids are shown in Fig. 1 .
Construction of in-frame deletions. In-frame deletions in icmT and icmS were constructed by PCR as described by Imai et al. (28) . The plasmid pGS-Lp-37 was used for the PCR mutagenesis. The primers that were used to construct the in-frame deletion in icmT were 5Ј-TCCGCTTCTCGCTGAGTCACG-3Ј (bases 435 to 417 in the sequence) and 5Ј-TCCCCGGTTTTTTTACGCTGG-3Ј (bases 573 to 591 in the sequence); the first two bases of both primers were changed from the original sequence to form a BamHI site after self-ligation (each primer contains half of a BamHI site at its 5Ј end). The primers that were used to construct the in-frame deletion in icmS were 5Ј-TCCCGCATTCATGCTTGCT GC-3Ј (bases 699 to 682 in the sequence) and 5Ј-TCCAGCCGTGATTATACT CCC-3Ј (bases 949 to 966 in the sequence); the first three bases of both primers were changed from the original sequence to form a BamHI site. The PCR conditions were as follows: 30 cycles at 95°C for 1 min, 60°C for 0.5 min, and 75°C for 5 min, performed in 100-l reaction mixtures by using the buffer supplied with the enzyme, 200 mM each nucleotide, 0.1 g of plasmid DNA, 50 pmol of each primer, and 2 U of Vent DNA polymerase. The PCR products were gel purified and self-ligated. After transformation, the plasmids prepared were examined for the presence of the BamHI site expected to be generated by the ends of the two primers. The plasmid harboring the in-frame deletion in icmT was named pGS-Lp-37-D1, and the plasmid harboring the in-frame deletion in icmS was named pGS-Lp-37-D2.
The in-frame deletion in icmP was constructed by using two NcoI sites located in the icmP coding region (bases 2342 and 2786 in the sequence). The plasmid pGS-Lp-34 was digested with NcoI and self-ligated to form pGS-Lp-34-D1, which contains an in-frame deletion in icmP. The inserts of the three plasmids described above were cloned into pMMB207␣b by using the EcoRI and HindIII sites of the polylinker. The internal letters of the plasmid name were changed from "Lp" to "Lc" to indicate the different vector.
Construction of plasmids for allelic exchange. The plasmids pAB-16 and pAB-17 (36) were used to reconstruct the wild-type EcoRI fragment of hybridization group 3. The EcoRI-SalI fragment from pAB-17 (containing the EcoRI fragment with the transposon from LELA3451) was joined to the SalI-EcoRI fragment from pAB-16 (containing the EcoRI fragment with the transposon from LELA3037), and both were cloned together into the EcoRI site of pUC-18 to generate pGS-Lp-14. The plasmid pGS-Lp-14 contains the whole 8. icmTSRQPO from pGS-cos-1 in pMMB207␣b This study pGS-Lc- 34 Insert from pGS-Lp-34 in pMMB207␣b This study pGS-Lc-34b
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Insert deletion was constructed in the manner described for the construction of pGSLp-34-D1, generating pGS-Lp-30-D1. This plasmid was digested with NcoI, and after it was filled in, the kanamycin resistance cassette (Pharmacia Biotech) was cloned into it to form pGS-Lp-30-D1-Km. To knock out the icmO gene, the kanamycin resistance cassette was cloned into the BamHI site (base 4352 in the sequence) located in the middle of the icmO gene, forming pGS-Lp-30-Ba-Km. The plasmids pGS-Lp-30-D1-Km and pGS-Lp-30-Ba-Km were digested with PvuII, and the inserts were cloned into the EcoRV site of the allelic exchange vector pLAW344, to form pGS-Le-30-D1-Km and pGS-Le-30-Ba-Km, respectively. In this step we found out that pGS-Lc-14 (which contains the insert of pGSLp-14 in pMMB207␣b) contains a mutation in icmR, as it failed to complement the icmR mutants. This finding led us to clone the wild-type DNA of hybridization group 3 from the pLAFR1 library, as described above. The inserts of both plasmids, pGS-Lc-14 and pGS-Lc-32 (both of which contain the 8.8-kb EcoRI fragment of DNA hybridization group 3), were sequenced from the BsaBI site to the Eco47III site (Fig. 1) . The mutation in icmR was the only difference found between the two plasmids. Because no changes were found in the icmPO region, the two plasmids described above were used to construct the gene replacements in icmP and icmO.
The plasmid constructed to make a knockout of icmS was subcloned from pGS-Lc-32, described above. A 1,586-bp fragment containing icmT, icmS, and icmR was subcloned, by using the BsaBI and StuI sites (bases 1 to 1586 in the sequence), into the HincII site of pUC-18 to generate pGS-Lp-33. An in-frame deletion was constructed in icmS, with the same primers and by the same method described for the construction of pGS-Lp-37-D2, to generate pGS-Lp-33-D2. The kanamycin resistance cassette was cloned into the BamHI site generated by the deletion to form pGS-Lp-33-D2-Km. The insert of this plasmid was cloned into pLAW344 in the manner described for pGS-Lp-30-D1-Km, to form pGSLe-33-D2-Km.
Allelic exchange. Allelic exchange was performed as previously described (42) . Briefly, the vector pLAW344, which contains a Cm r marker and the counterselectable sacB gene from Bacillus subtilis, was used to mediate allelic exchange. The plasmids pGS-Le-33-D2-Km, pGS-Le-30-D1-Km, and pGS-Le-30-Ba-km (described above) were introduced into L. pneumophila JR32 by electroporation, grown in AYE for 5 h, and plated on ABCYE containing KM and CM. Transformants were patched on ABCYE plates containing KM and were then streaked on ABCYE plates containing KM and 2% (wt/vol) sucrose in order to select for cells that no longer contained pLAW344 sequences. Km r Suc r single isolates were patched on ABCYE plates containing KM and ABCYE plates containing CM. Km r Cm s isolates were tested by Southern hybridization for the correct change; at least four independent isolates were tested for each allelic exchange.
HL-60 cell culture. The human leukemia cell line HL-60 (12) was maintained in RPMI supplemented with 2 mM Gln and 10% FBS at 37°C under CO 2 (5%). HL-60 cells were differentiated into macrophages by incubation for 48 h with 10 ng of phorbol 12-myristate 13-acetate/ml in RPMI containing 2 mM Gln and 10% NHS. Adherent cells were washed three times with RPMI containing 2 mM Gln and were incubated with RPMI containing 2 mM Gln and 10% NHS before infection.
Cytotoxicity assay. The cytotoxicity assay was carried out as described previously (31) . Briefly, wells of a 96-well microtiter dish containing 4 ϫ 10 5 differentiated HL-60-derived macrophages were infected with 10-fold serial dilutions of L. pneumophila in RPMI, starting with about 10 8 bacteria/well. After 6 days of incubation at 37°C, the dye MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) was added to each well at a concentration of 0.5 mg/ml. After incubation at 37°C for 4 h, the culture medium was removed and the remaining reduced formazan dye was suspended in 100 l of isopropanol containing 0.04 M HCl and 1% sodium dodecyl sulfate. The A 570 values of three wells containing the same multiplicity of infection (MOI) were averaged to determine the extent of macrophage killing.
Intracellular growth assay. Wells of a 96-well microtiter dish containing 4 ϫ 10 5 differentiated HL-60-derived macrophages were used for infection. L. pneumophila was added to the wells at an MOI of approximately 0.01 and was centrifuged for 5 min at 800 ϫ g. The infected HL-60 cells were incubated at 37°C under CO 2 (5%), and bacterial CFU were determined 0, 24, 48, and 72 h after infection. The number of CFU in a whole well was determined by removing the culture medium, adding 100 l of deionized H 2 O to the cell monolayer, combining the two fractions, and plating samples on ABCYE plates. Each infection was performed in triplicate.
DNA sequencing and sequence analysis. All the sequences were generated by the DNA Synthesis and Sequencing Facility of the Comprehensive Cancer Center, College of Physicians and Surgeons of Columbia University. DNA sequences and amino acid sequences of potential open reading frames (ORFs) were compared to sequences in the GenBank, EMBL, and SwissProt databases by using the programs BLAST and FASTA. Motif searches were carried out by using the Prosite program (3), and the locations of proteins in the cell were predicted by using the Psort program (34) . The number of transmembrane domains was determined by the TMpred program (20) , the isoelectric points and molecular weights of the proteins were calculated with the Compute pI/Mw program (7), and sequence alignment was carried out by using the SIM program (27) .
Nucleotide sequence accession number. Sequence data for the complete icmTSRQPO locus have been assigned EMBL data accession no. Y12705.
RESULTS
Cloning of the wild-type DNA fragment. In a previous report, a collection of 55 L. pneumophila mutants defective for macrophage killing was described. Nine of these mutants were assigned to the same DNA hybridization group (group 3). In addition, the EcoRI fragment containing the transposon was cloned from three of these mutants (36) .
To characterize this DNA hybridization group, the wild-type EcoRI fragment that covers this region was cloned from an L. pneumophila cosmid library. Several positive cosmids were identified, all of which contain the same 8.
Genes and proteins found in the region. The region that was sequenced (6,432 bp, from the BsaBI site to the Eco47III site [ Fig. 1] ) was found to contain six genes, designated icmT, icmS, icmR, icmQ, icmP, and icmO. The locations of the transposon insertions were determined by sequencing, and five of the genes (icmTRQPO) were found to contain at least one transposon insertion. The organization of the genes and the locations of the transposons are presented in Fig. 1 and Table 3 . Sequence homology searches against the EMBL, GenBank, and SwissProt databases were conducted with these genes and the corresponding proteins. icmP and icmO were found to have significant homology with the trbA and trbC genes from Salmonella plasmid R64 (17), respectively. IcmP and TrbA were found to be 23% identical and 35% similar over 376 amino acids. IcmO and TrbC were found to be 24% identical and 36% similar over 783 amino acids. trbA and trbC were shown to be part of an operon containing the trbB gene between them (17); we found that icmP and icmO form an operon as well (see below). The other four genes found in this region are novel genes. Several properties of the six proteins are presented in Table 4 .
Complementation of the mutants. The cytotoxicities for HL-60-derived macrophages of strains containing the vector (pMMB207␣b) were compared with those of strains carrying pGS-Lc-32. The introduction of the vector had no effect on the strains' ability to kill HL-60-derived macrophages (data not shown). On the other hand, pGS-Lc-32 ( Fig. 1) , which contains the 8.8-kb EcoRI fragment that covers the whole group 3 region, complemented the mutants (Fig. 2) . As can be seen in Fig. 2C and D, the mutants that contain a transposon in icmR (LELA3278 and LELA3473) or icmQ (LELA3463 and LELA 4378) retain some ability to kill HL-60-derived macrophages, in contrast to the avirulent mutant 25D (21) . These four strains were complemented completely with pGS-Lc-32. The strains carrying mutations in icmT (LELA4086), icmP (LELA3352, LELA3037, and LELA3451), or icmO (LELA4032) were completely defective in their ability to kill HL-60-derived macrophages, and they were only partially complemented with pGSLc-32 ( Fig. 2A, E, and F) . As mentioned above, no transposon insertion was found in icmS. To test if icmS is needed for macrophage killing, a kanamycin resistance cassette was introduced into it. The resulting mutant (GS3001) (Fig. 1 ) was found to be attenuated for macrophage killing, and it was partially complemented with pGS-Lc-32 (Fig. 2B) .
The icmT and icmS genes. Plasmids pGS-Lc-37 and pGS-Lc37b, which contain the icmS and icmT genes (Fig. 1) , partially complemented LELA4086 and GS3001 for macrophage killing (Fig. 3) . This result indicates that the insertions located in these two genes are not polar on the downstream icm genes (icmRQPO).
The mutants that we studied were generated by insertion mutagenesis, and they may act by polarity to decrease expression of downstream genes within the same transcriptional unit. GS3001, which contains an insertion in icmS, was only partially attenuated for macrophage killing (Fig. 2B) ; therefore, it is not possible that the transposon in icmT acts only by polarity on icmS. On the other hand, it is possible that both genes (icmT and icmS) are only partially required for macrophage killing and that the absence of both gene products (due to polarity of the transposon in icmT) results in complete attenuation for macrophage killing. To distinguish between these two possibilities, nonpolar in-frame deletions were generated in the complementing plasmid pGS-Lc-37. The plasmid pGS-Lc-37-D1 contains an in-frame deletion in icmT, and as can be seen in Fig. 3 , it cannot complement LELA4086 but it does complement GS3001. The plasmid pGS-Lc-37-D2 contains an in-frame deletion in icmS. This plasmid cannot complement GS3001, but it restores the ability of LELA4086 for macrophage killing to a level similar to that observed for GS3001 (Fig. 3) . These results indicate that the transposon located in icmT (LELA4086) is polar on icmS but that the lack of the icmT gene product by itself results in complete attenuation for macrophage killing. These complementation results also indicate that icmT and icmS probably form a single transcriptional unit.
The icmR and icmQ genes. Both icmR mutants (LELA3278 and LELA3473) were complemented by pGS-Lc-36 and pGSLc-36b (Fig. 4A) , which contain the icmR gene on a 644-bp ( Fig. 1) fragment (in opposite orientations) . The same result was obtained for both icmQ mutants (LELA3463 and LELA 4378) complemented by pGS-Lc-35 and pGS-Lc-35b (Fig. 4B) , which contain the icmQ gene on a 1,037-bp (Fig. 1 ) fragment (in opposite orientations).
These results indicate that the transposon insertions in icmR and icmQ are not polar on downstream icm genes and that these two genes are probably transcribed as monocistronic mRNAs. The icmP and icmO genes. The four strains with insertion mutations in icmP and icmO (icmP mutants LELA3352, LELA 3451, and LELA3037, and icmO mutant LELA4032) were partially complemented by pGS-Lc-32 ( Fig. 2E and F) . The three icmP mutants were also complemented, to the same level, by pGS-Lc-34, which contains the icmP and icmO genes (Fig. 1) , but the icmO mutant was not complemented by this plasmid (data not shown). Because of the complementation problems described above, new mutants with insertions in icmP and icmO were constructed (see Materials and Methods).
The new insertion mutants, the icmP mutant GS3002 and the icmO mutant GS3003, were partially complemented by pGS-Lc-32, as well as by pGS-Lc-34 and pGS-Lc-34b (Fig. 5) . The observation that the new icmO mutant (GS3003) was complemented by pGS-Lc-34, whereas the original mutant (LELA4032) was not, may indicate that LELA4032 contains an additional mutation in one or more of the other four genes located in this region (icmTSRQ). This assumption is based on the fact that both LELA4032 and GS3003 were complemented by pGS-Lc-32 ( Fig. 2F and 5B) .
To test if icmP by itself is required for macrophage killing or if the insertions located in it act by polarity on icmO, a nonpolar in-frame deletion was constructed in icmP. The plasmid pGS-Lc-34-D1, which contains the in-frame deletion in icmP, was tested for its ability to complement GS3002 and GS3003 (Fig. 5) . As expected, this plasmid was able to complement the icmO mutant (GS3003) but failed to complement the icmP mutant (GS3002). A plasmid containing only icmP failed to complement insertions in icmP (data not shown). These results indicate that both icmP and icmO are required for macrophage killing and that they are probably transcribed as a single transcriptional unit.
The homology found between icmP and trbA, as well as that between icmO and trbC, led us to test whether L. pneumophila strains are able to conjugate small plasmids between one another. We first tested if the IncQ plasmid pMMB207␣b can be conjugated from the wild-type strain JR32 to a rifampin-resistant JR32 recipient strain. We found that this plasmid was conjugated at a frequency of about 10
Ϫ4
, which is 4 log units higher than the frequency at which spontaneous rifampin resistance strains were found. To determine if icmP and icmO are required in order to conjugate pMMB207␣b, we tested whether conjugation still occurs with GS3002, which contains an insertion in icmP (in this strain, neither icmP nor icmO is expressed). When this mutant was used as a donor, the conjugation frequency was reduced 30-fold over that with the wildtype strain. The conjugation frequency was restored to the wild-type level when conjugation was carried out with this mutant containing the complementing plasmid pGS-Lc-34.
The mutants are defective in intracellular multiplication. The abilities of strains carrying mutations in the six genes described in this report to multiply inside HL-60-derived mac- rophages were determined by assaying the changes in bacterial CFU during infection. One mutant was assayed for each gene. In the cases of mutants that contain an insertion in a monocistronic transcriptional unit (icmQ and icmR) or in the second gene of an operon (icmS and icmO), a comparison was performed between a mutant containing the vector and a mutant containing a complementing plasmid (Table 5 ). In the cases of mutants that contain an insertion in the first gene of an operon (icmT and icmP), the ability to multiply was compared between a strain containing a plasmid with an in-frame deletion in the first gene of the operon and a mutant containing a complementing plasmid (Table 5 ). In the latter case, the comparison was done in this way in order to determine the requirement of the first gene of the operon and not of the whole operon.
As can be seen in Table 5 , mutants containing insertions in icmT, icmR, icmQ, icmP, and icmO were unable to multiply within HL-60-derived macrophages, and they were killed by the cells. Mutants containing insertions in icmT, icmP, and icmO were killed more efficiently than mutants containing insertions in icmR and icmQ. All these mutants regained their ability to grow inside HL-60-derived macrophages when a complementing plasmid was introduced into them, but different levels of complementation were observed with different mutants. The icmS mutant (GS3001) was able to grow inside HL-60-derived macrophages, but its multiplication was slower than the multiplication observed for this strain with a complementing plasmid. The results obtained from the intracellular multiplication experiments agree with the results of the cytotoxicity assays, described above.
DISCUSSION
L. pneumophila is a facultatively intracellular pathogen that overcomes many natural host defense mechanisms, enabling it to cause disease in humans. Like Mycobacterium tuberculosis (2) , Chlamydia psittaci (16) , and Toxoplasma gondii (29) , L. pneumophila infects human cells, survives, and multiplies within a specialized vacuole that does not fuse with secondary lysosomes (23) . Although it has been known for some time that L. pneumophila grows within a specialized vacuole and changes the ability of the vacuole to fuse with lysosomes, it has not yet been established which genes directly control the ability of the organism to prevent phagosome-lysosome fusion.
In a previous study, a collection of 55 insertion mutants that showed a partial or complete block to their ability to kill HL-60-derived macrophages was isolated. Forty-nine of these mutants were assigned to 16 DNA hybridization groups (36) . One of these groups (group 1) had already been characterized and was reported to contain the icmWXYZ and dotA genes. The icm genes were shown to be required for intracellular multiplication (8) , and dotA mutants were found to have defects in organelle trafficking and were unable to grow within human macrophages (6) .
In the present study, we characterized an additional locus containing six new genes, all of which were shown to be required for macrophage killing. The differences between mutations in different genes were quantitated in a cytotoxicity assay and in an intracellular growth experiment. These six genes can be divided into three groups: (i) icmT, icmP, and icmO, (ii) icmR and icmQ, and (iii) icmS. Mutants containing an insertion in the first group of genes (icmT, icmP, and icmO) completely lost their ability to kill HL-60 cells, and they were killed by the cells. Mutants containing an insertion in the second group of genes (icmR and icmQ) were found to have a moderate reduction in their ability to kill HL-60 cells, as killing was still observed at a high MOI. Mutants containing insertions in these genes were killed by the cells, but less efficiently than the mutants of the first group. The mutant containing an insertion in icmS was found to have a slight reduction in its ability to kill HL-60 cells, and it was able to multiply intracellularly, but less efficiently than the wild-type strain.
All the mutants were complemented for both the ability to kill and the ability to multiply within HL-60-derived macrophages, although different levels of complementation were observed for different genes. Mutants containing insertions in icmT, icmS, icmP, and icmO were partially complemented for macrophage killing, and mutants containing insertions in icmR and icmQ were complemented completely. On the other hand, icmS, icmQ, icmP, and icmO mutants were complemented better for growth inside HL-60 cells than icmT and icmR mutants. In the case of the icmR mutant, complete complementation for cell killing was observed in the cytotoxicity assay (Fig. 4A ), but it was only partially complemented for growth inside HL-60 cells (Table 5 ). The variability in the degree of complementation may result from different expression of the genes from the plasmid and the chromosome. Four of the proteins described in this paper (IcmT, IcmS, IcmR, and IcmQ) bear no homology to known prokaryotic or (Fig. 6 ), respectively. Both IcmO and TrbC are predicted to form two transmembrane domains at the N-terminal end, and each contains an ATP-or GTP-binding site at the same distance from the predicted transmembrane domains. . The homology between IcmP and TrbA was found to be 23% identity and 35% similarity over 376 amino acids. IcmO and TrbC were found to be 24% identical and 36% similar over 783 amino acids. Identical amino acids are shown on a solid background; similar amino acids (shaded) are I, L, V, and M; H, K, and R; D and E; T and S; and Q and N.
FIG. 7.
Comparison among the icmTS, icmR, icmQ, icmPO, icmW, icmB, and icmF upstream regulatory regions. The sequence of icmTSRQPO is from EMBL accession no. Y12705, the sequence of icmW is from EMBL accession no. U07354, and the sequences of icmB and icmF are from reference 35a. The first ATG codon of each gene is in boldface, the putative ribosomal binding sites are in italics, and the bases that match the putative consensus promoter sequence are underlined. The number of matches and the percent identity with the consensus sequence are indicated to the right.
Moreover, the two proteins show 24% identity and 36% similarity over 783 amino acids (Fig. 6B) . IcmP, which forms an operon with IcmO, was found to contain a significant degree of homology (23% identity and 35% similarity over 376 amino acids) with TrbA, which forms an operon with TrbC (Fig. 6A) . The trbA and trbC genes were shown to be part of an operon containing three genes-trbABC (17) . This operon was shown to be located within the transfer region of the IncI1 plasmid R64, adjacent to the oriT operon, in the opposite orientation. The trbA and trbC genes were shown to be indispensable for R64 transfer, while residual transfer was detected in a trbB deletion mutant. The connection between the ability of L. pneumophila to conjugate small plasmids, which was significantly reduced in an icmPO mutant, and its ability to kill human macrophages, which was completely abolished in this mutant, is currently not known.
Although several genes involved in L. pneumophila's ability to kill macrophages were cloned and sequenced, there is no information regarding promoters or transcription factors that regulate these genes. The complementation results presented in this paper indicate that the genes described are probably arranged as two operons (icmTS and icmPO) and two genes (icmR and icmQ). Careful analysis of the upstream regulatory regions of these genes and operons revealed a conserved sequence that might serve as a promoter or a recognition site for a transcription factor (Fig. 7) . This sequence was also found upstream of icmW (8) , as well as upstream of icmB and icmF (35a) .
Two (of sixteen) DNA hybridization groups (groups 1 and 3) have been characterized so far. These two groups were found to contain 11 genes (icmWXYZ, dotA, and icmTSRQPO), all of which, except for icmO and icmP, show no homology to other known genes or proteins. This finding may indicate that L. pneumophila has developed a previously unrecognized system for survival and replication inside human macrophages.
